The APOL1 gene and kidney transplantation: a review article.

Abstract excerpt

INTRODUCTION: Chronic kidney disease (CKD) is a global public health problem and kidney transplantation is the treatment of choice for patients with stage 5 (G5) CKD. Kidney transplant survival at the end of the first year exceeds 95%, and at 5 years, it approaches 90%. However, the decline in the estimated glomerular filtration rate (eGFR) over the years remains a challenge. The rate of eGFR decline is...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Apolipoprotein L1
• Share to Donor Selection
• Share to Glomerular Filtration Rate